• / Free eNewsletters & Magazine
  • / My Account
Home>Perrigo rejects Mylan bid of $205 a share

Perrigo rejects Mylan bid of $205 a share

3party Content

Tue, 21 Apr 2015

Irish drug maker Perrigo Co. PLC (PRGO) on Tuesday rejected Mylan N.V.'s (MYL) takeover bid of $205 a share, thus complicating a merger triumvirate that also includes Teva Pharmaceuticals Industries (TEVA) . In a press release, Perrigo said Dutch-based Mylan's bid, disclosed April 8, "substantially
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.